Annalisa Tondo

1.1k total citations
36 papers, 386 citations indexed

About

Annalisa Tondo is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, Annalisa Tondo has authored 36 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Annalisa Tondo's work include Neuroblastoma Research and Treatments (13 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Annalisa Tondo is often cited by papers focused on Neuroblastoma Research and Treatments (13 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Annalisa Tondo collaborates with scholars based in Italy, Israel and France. Annalisa Tondo's co-authors include Claudio Favre, Alberto Garaventa, Maura Calvani, Simone Cesaro, Gennaro Bruno, Francesco Pegoraro, Francesca Carraro, Cristina Meazza, Federica Galaverna and Luca Filippi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Annalisa Tondo

28 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annalisa Tondo Italy 11 140 116 92 65 64 36 386
Andreas Lossius Norway 14 121 0.9× 71 0.6× 98 1.1× 45 0.7× 284 4.4× 26 723
Baoqin Gao China 17 87 0.6× 50 0.4× 120 1.3× 19 0.3× 19 0.3× 28 426
Giada Licata Italy 14 39 0.3× 134 1.2× 133 1.4× 114 1.8× 31 0.5× 23 607
Joseph Bruno Bidin Brooks Brazil 12 36 0.3× 102 0.9× 73 0.8× 30 0.5× 76 1.2× 36 409
Makoto Nakamura Japan 11 66 0.5× 22 0.2× 82 0.9× 21 0.3× 48 0.8× 43 371
S. Ali Nabavizadeh United States 9 50 0.4× 71 0.6× 61 0.7× 13 0.2× 74 1.2× 25 383
Simona Toscano Italy 11 95 0.7× 148 1.3× 45 0.5× 36 0.6× 60 0.9× 24 422
Caleb Cornaby United States 12 54 0.4× 39 0.3× 88 1.0× 42 0.6× 236 3.7× 25 535
Christine Lombard France 12 54 0.4× 98 0.8× 72 0.8× 57 0.9× 89 1.4× 33 412
Aurélie Ladang Belgium 12 93 0.7× 39 0.3× 275 3.0× 19 0.3× 24 0.4× 21 480

Countries citing papers authored by Annalisa Tondo

Since Specialization
Citations

This map shows the geographic impact of Annalisa Tondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa Tondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa Tondo more than expected).

Fields of papers citing papers by Annalisa Tondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annalisa Tondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa Tondo. The network helps show where Annalisa Tondo may publish in the future.

Co-authorship network of co-authors of Annalisa Tondo

This figure shows the co-authorship network connecting the top 25 collaborators of Annalisa Tondo. A scholar is included among the top collaborators of Annalisa Tondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annalisa Tondo. Annalisa Tondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amoroso, Loredana, Franca Fagioli, Annalisa Tondo, et al.. (2025). Strategies to manage the adverse effects of immunotherapy with dinutuximab beta in neuroblastoma: an Italian experience and literature review. Supportive Care in Cancer. 33(3). 153–153.
2.
Montagnani, Carlotta, et al.. (2025). Pediatric central line-associated bloodstream infections management: A retrospective study. American Journal of Infection Control. 54(4). 376–381.
3.
Pegoraro, Francesco, Francesco Peyronel, Matthias Papo, et al.. (2025). Risk of Second Cancer in Erdheim-Chester Disease. JAMA Oncology. 11(4). 429–429. 2 indexed citations
4.
Bencini, Erica, Annalisa Tondo, Angela Tamburini, et al.. (2025). Ovarian function in adolescents and young adults undergoing cancer treatment: biochemical and ultrasound marker analysis. Endocrine Connections. 14(4).
5.
6.
Trambusti, Irene, Carmen Barba, Marzia Mortilla, et al.. (2024). A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study. Frontiers in Immunology. 15. 1422802–1422802. 1 indexed citations
7.
Pegoraro, Francesco, Aurora Chinnici, Michele Tanturli, et al.. (2024). Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry. Haematologica. 109(8). 2515–2524. 1 indexed citations
8.
Pastorino, Fabio, Mario Capasso, Chiara Brignole, et al.. (2023). Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology. Cancers. 15(3). 560–560. 5 indexed citations
9.
Bruno, Gennaro, Laura Pietrovito, Angela Leo, et al.. (2023). Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma. Cancers. 15(19). 4744–4744. 4 indexed citations
10.
Pegoraro, Francesco, et al.. (2023). Targeted treatment of solid tumors in pediatric precision oncology. Frontiers in Oncology. 13. 1176790–1176790. 8 indexed citations
11.
Pastorino, Fabio, Mario Capasso, Chiara Brignole, et al.. (2022). Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations. International Journal of Molecular Sciences. 23(19). 11236–11236. 1 indexed citations
12.
Damm‐Welk, Christine, Federica Lovisa, Elisa Carraro, et al.. (2022). Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?. Cancers. 14(7). 1703–1703. 11 indexed citations
13.
Bottino, Cristina, Mariella Della Chiesa, Stefania Sorrentino, et al.. (2022). Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants. Cancers. 14(19). 4548–4548. 4 indexed citations
14.
15.
Parodi, Stefano, Stefania Sorrentino, Andrea Di Cataldo, et al.. (2021). Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry. Pediatric Blood & Cancer. 68(5). e28904–e28904. 1 indexed citations
16.
Mannurita, Sara Ciullini, Maria Luisa Coniglio, Annalisa Tondo, et al.. (2021). Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia. Frontiers in Immunology. 11. 620046–620046. 8 indexed citations
17.
Bruno, Gennaro, Francesca Cencetti, Alessandro Pini, et al.. (2019). β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation. Oncogene. 39(2). 368–384. 40 indexed citations
18.
Calvani, Maura, Lorenzo Cavallini, Annalisa Tondo, et al.. (2018). β3‐Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells. Oxidative Medicine and Cellular Longevity. 2018(1). 6816508–6816508. 39 indexed citations
19.
Pillon, Marta, Lara Mussolin, Elisa Carraro, et al.. (2016). Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B‐Cell Lymphoma treated with theAIEOP LNH‐97 protocol. British Journal of Haematology. 175(3). 467–475. 26 indexed citations
20.
Pugi, Alessandra, Silvia Benemei, Maria Teresa Vietri, et al.. (2011). Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review. Journal of Clinical Pharmacy and Therapeutics. 37(2). 245–248. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Lossius Breakdown of academic impact, for papers by Baoqin Gao Breakdown of academic impact, for papers by Giada Licata Breakdown of academic impact, for papers by Joseph Bruno Bidin Brooks Breakdown of academic impact, for papers by Makoto Nakamura Breakdown of academic impact, for papers by S. Ali Nabavizadeh Breakdown of academic impact, for papers by Simona Toscano Breakdown of academic impact, for papers by Caleb Cornaby Breakdown of academic impact, for papers by Christine Lombard Breakdown of academic impact, for papers by Aurélie Ladang
Rankless by CCL
2026